Hong Kong Stock Market News | Lai Kai Pharmaceuticals-B (02105) rose more than 22%, hitting a new high for the year. Recently announced clinical cooperation with eli lilly and co on a new type of weight loss drug.
The stock price of Lai Kai Pharmaceutical-B (02105) rose by over 22%, reaching a high of HK$17.4, setting a new high for the year. As of the time of publication, it has increased by 22.48%, trading at HK$17, with a turnover of 0.178 billion Hong Kong dollars.
Futu Morning News | Official announcement! Trump nominates Benset to serve as usa Secretary of the Treasury; Goldman Sachs is bullish on US stocks: the s&p 500 will rise to 7000 points.
Goldman Sachs 2025 csi commodity equity index outlook: Long gold is the "Top Trade", oil & gas prices may see a "temporary uptrend"; USA PMI in November hit the fastest level since April 2022, factories increase purchases of imported inputs; USA election settled, consumer confidence lower than expected, long-term inflation expectations breaking through the range top.
Eli Lilly's (LLY) Breakthroughs: Hedge Funds' New Healthcare Favorite
Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC